Ticker Scorecard - ARQT Basics Company: Arcutis Biotherapeutics, Inc. IPO Date: January 31, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.49B Activated in VL: True Average Daily Range Avg Daily Range: $0.59 | 3.45% Avg Daily Range (30 D): $0.44 | 3.10% Avg Daily Range (90 D): $0.36 | 3.02% Institutional Daily Volume Avg Daily Volume: 1.02M Avg Daily Volume (30 D): 1.68M Avg Daily Volume (90 D): 1.66M Trade Size Avg Trade Size (Sh.): 110 Avg Trade Size (Sh.) (30 D): 83 Avg Trade Size (Sh.) (90 D): 92 Institutional Trades Total Inst.Trades: 1,657 Avg Inst. Trade: $1.79M Avg Inst. Trade (30 D): $2.11M Avg Inst. Trade (90 D): $2.1M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.21M Avg Closing Trade (30 D): $3.2M Avg Closing Trade (90 D): $2.68M Avg Closing Volume: 190.58K     News Jan 12, 2025 @ 1:30 PM Arcutis Announces Preliminary Unaudited Fourth Qua... Source: N/A Jan 6, 2025 @ 9:00 PM Arcutis Biotherapeutics Reports Inducement Grants ... Source: N/A Nov 6, 2024 @ 9:00 PM Arcutis Announces Third Quarter 2024 Financial Res... Source: Arcutis Biotherapeutics, Inc. Oct 23, 2024 @ 8:00 PM Arcutis to Report Third Quarter 2024 Financial Res... Source: N/A Jul 17, 2024 @ 2:01 PM Arcutis (ARQT) Stock Rises 31% in the Past Month: ... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.66 $-.33 $-.42 Diluted EPS $-1.66 $-.33 $-.42 Revenue $ 138.71M $ 44.76M $ 30.86M Gross Profit $ 124.24M $ 39.25M $ 27.39M Net Income / Loss $ -195.54M $ -41.54M $ -52.33M Operating Income / Loss $ -181.93M $ -39.07M $ -50.08M Cost of Revenue $ 14.47M $ 5.5M $ 3.46M Net Cash Flow $ 27.01M $ 50.48M $ -105.8M PE Ratio